Dayima

Beijing, China Founded: 2012 • Age: 14 yrs
Periods and womens health are tracked via a mobile app.

About Dayima

Dayima is a Healthcare company based in Beijing (China) founded in 2012 by Chai Ke. Periods and womens health are tracked via a mobile app. Dayima has raised $75.6 million across 8 funding rounds from investors including European Union, Haitong Securities and By-Health. Its focus areas include HealthTech, Disease Self Management, Women Health and Monitoring.

Company details

Dayima was founded in 2012 in Beijing, China, within the womens health technology sector. A mobile application is operated to track menstrual cycles based on historical data. Predictions for future periods are generated, alongside health advice for managing cramps and pre-menstrual symptoms. Connections to online forums are facilitated for user discussions on parenting, beauty, and related topics.

  • Headquarters Beijing, China
  • Founders Chai Ke
  • Sectors
    Healthcare
  • Website dayima.com
  • Social LinkedIn
Key Metrics
  • Total Equity Funding
    $75.6M (USD)

    in 8 rounds

  • Latest Funding Round
    $160K (USD), Grant

    Mar 2023

  • Investors

Funding Insights of Dayima

Dayima has successfully raised a total of $75.6M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $160 thousand completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $75.6M
  • Total Rounds 8
  • Last Round Grant β€” $159,998
  • First Round $5M

    (Apr 2013)

  • Investors Count 7

All 8 funding rounds of Dayima with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2023$159,998Grant––
Dec 2021Grant––
Oct 2015$20.5MSeries E––
Jul 2015$10.1MSeries D––
Jun 2014$30MSeries C–Ceyuan Ventures
Sep 2013$10MSeries B–Zhen Fund, Sequoia Capital
–
Aug 2013Series A––
–
Apr 2013$5MSeries A–Zhen Fund, BAI Capital
–
Valuation history

7 investors in total: 7 institutional.

Investors in Dayima

Dayima has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Haitong Securities and By-Health.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early-stage tech investments in China are managed by Ceyuan Ventures.
ceyuan.comHong Kong, China
Sequoia Capital is engaged in venture capital investments.
1972sequoiacap.com
BAI Capital is engaged in investment and financial services.
bai-cap.comBeijing, China
Tech & Offline focused Seed stage VC Firm investing primarily in Asia and the US
zhenfund.comBeijing, China
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Financial services such as brokerage and asset management are offered.
1988htsec.comShanghai, China
Dietary supplements are manufactured by By-Health in China.
1995by-health.comGuangzhou, China
Premium access

Investor details for Dayima

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Dayima

1 people are tracked at Dayima (1 in leadership).

NameRoleGroup
Chai Ke
FounderLeadership
Premium access

Complete people profiles for Dayima

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Dayima

3 dated milestones of Dayima across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Dayima is founded.
  2. Funding First funding round of $5.0M.
  3. Funding Latest funding round, Grant, of $160K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Dayima

Dayima was founded in 2012 and raised its 1st funding round 1 year after it was founded.

Dayima is headquartered in Beijing, China.

Dayima is a funded company, having raised a total of $75.6M across 8 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Apr 2013.

Dayima was founded in 2012 in Beijing, China, within the womens health technology sector. A mobile application is operated to track menstrual cycles based on historical data. Predictions for future periods are generated, alongside health advice for managing cramps and pre-menstrual symptoms. Connections to online forums are facilitated for user discussions on parenting, beauty, and related topics.

Dayima has 7 investors. Key investors include European Union, Haitong Securities, By-Health, Ceyuan Ventures, and Sequoia Capital.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available